IA
WST icon

Icon Advisers’s West Pharmaceutical WST Stock Holding History

Icon Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-22,800
Closed -$1.02M – 349
2014
Q3 		$1.02M Hold
22,800
– – 0.06% 222
2014
Q2 		$962K Buy
+22,800
New +$976K 0.06% 225

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Icon Advisers's WST Position: Q4 2014 in Review

Icon Advisers sold out of West Pharmaceutical (WST) in Q4 2014, closing a stake of 22,800 shares — an estimated $1.02M sold.

Icon Advisers first reported a position in WST in Q2 2014 and held it in 2 quarters. The position peaked at $1.02M in Q3 2014. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • Icon Advisers reported no remaining West Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • Icon Advisers sold 22,800 West Pharmaceutical shares in Q4 2014, an estimated $1.02M.
  • Icon Advisers first reported a position in West Pharmaceutical in Q2 2014 and held it in 2 quarters.
  • Icon Advisers's West Pharmaceutical position peaked at $1.02M in Q3 2014.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Icon Advisers's 13F filing for Q4 2014, filed 22 Jan 2015.